# Nasal and Systemic Immune Responses to Nasal Influenza Vaccine

> **NCT04110366** · NA · COMPLETED · sponsor: **Imperial College Healthcare NHS Trust** · enrollment: 48 (actual)

## Conditions studied

- Influenza
- Vaccine Virus Shedding

## Interventions

- **BIOLOGICAL:** Live attenuated influenza vaccine
- **OTHER:** Vehicle control

## Key facts

- **NCT ID:** NCT04110366
- **Lead sponsor:** Imperial College Healthcare NHS Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-14
- **Primary completion:** 2019-04-04
- **Final completion:** 2020-05-29
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04110366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04110366, "Nasal and Systemic Immune Responses to Nasal Influenza Vaccine". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04110366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*